Company intelligence / Profile preview

Molecular Design Consulting

Birmingham, Alabama, United Statesmoleculardesigns.com ↗

Ownership: Private
Employees: ~55
Development stage: Other

Overview

Molecular Designs develops and supplies highly sensitive multiplex molecular diagnostic assays for pathogen detection. Their commercialized products include customizable PCR panels covering over 50 targets with applications in infectious disease diagnosis. They emphasize cost-effectiveness and workflow efficiency. No clinical trial results are reported as these are IVDs.

Therapeutic areas: Infectious Diseases
Modalities: PCR-based diagnosticsMolecular testing assays
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Molecular Design Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molecular Design Consulting.

Explore the full profile